Abstract -A fast detection algorithm for venous air embolism (VAE) was developed and implemented as a real-time monitor for detecting embolic heart sound and estimating embolic air volume. Its performance was evaluated under bolus injection of sub-clinical (0.01 to 0.80 ml) and continuous infusion of clinically significant (0.80 to 9.60 ml) air volumes in anaesthetized dogs. The clinically significant air emboli could be estimated based on the calibration curve obtained during sub-clinical VAE for a subject. The monitor also kept track of the cumulative embolic air volumes and alerted the anaesthetists once a predefined clinically significant embolic air volume was reached. As both humans and dogs share similar physiological conditions, our monitor for dogs are expected to be applicable to humans.
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I. INTRODUCTION
Venous air embolism (VAE), when occurs in large quantity during surgery, is a potential hazard to patients. Precordial Doppler ultrasound is one of the most sensitive and non-invasive monitorings for VAE [ 1, 21 but it requires the constant attention of anaesthetists to listen to subtle changes in the Doppler heart sound (DHS). Besides, it cannot provide the volume of air entering the heart chamber. Such information is crucial as anaesthetists usually act only when clinically significant embolic air volume is present [ 3 ] . Hence, a real-time monitor which can automatically detect the embolic heart sound (EHS) and estimate the embolic air volume is useful for easing the burden of anaesthetists for detecting and assessing the risk of VAE.
In this study, we investigated the DHS under simulated conditions of both sub-clinical (below 1 ml) and clinically significant (up to 10 ml) VAE in anaesthetized dogs. With wavelet analysis [4, 51, we greatly enhanced the contrast of embolic to normal DHS signal power, facilitating the detection of EHS simply by thresholding. We also developed a fast detection algorithm and implemented it as a real-time monitor for VAE. Based on the calibration curve obtained during sub-clinical VAE, we could estimate the embolic air volume related to each EHS for a subject. Moreover, we could keep track of the cumulative embolic air volumes and alert the anaesthetists when a predefined clinically significant embolic air volume was reached.
THEORY

A. Wavelet Analysis
Wavelet analysis is a linear operation which decomposes a signal into components that appear at different scales. The signal is divided into two parts by the wavelet analysis at scale = 1 based on its spectrum. The low-pass signal (known as the approximation signal) is a coarser approximation of the original signal while the high-pass signal (known as the difference signal) is the difference between them. The same procedure is applied to the approximation signals during wavelet analysis at successive scales. We can compute the approximation signal A,, f ( x ) and difference signal D 2 \ f ( x ) of the DHS signal at scale s using the following algorithm [4] :
where we define, for normalization purpose, the original DHS signal as the approximation signal at scale = 0, i.e., 
A,,,f(x)
.
B. Moving Square Average
Embedding the energy calculation in the moving average [6] , we define the moving square average (MSA) of a function f ( x ) as With a constant scaling of L + A4 + 1 (i.e. the window length), (3) can be reduced to
It can be shown that the MSA can be computed in a more computationally efficient way as where the window length is equal to the sum of wI and w2 . The MSA is useful for detecting EHS.
111. EXPERIM~N I The study was approved by the Animal Research Committee of the Veterans General Hospital-Taipei, Taiwan. Four mongrel dogs, weighing 10-15 kg, were anaesthetized and placed in the supine position with their lungs being mechanically ventilated. To simulate the sub-clinical and clinically significant VAE, we performed a series of bolus injection of small air volumes (0.01, 0.02, 0.05, 0.07, 0.10, 0.15, 0.20, 0.30, 0.40 and 0.80 ml), followed by continuous infusion of larger volumes (0.80, 1.60, 2.40, 4.80 and 9.60 ml) at various controlled rates of 0.011-0.192 ml kg-' min.' over 5 minutes via the right external jugular vein. Preinjection baseline period (5 minutes) and intermission in between successive infusions (2 to 5 minutes) were allowed. The DHS during the entire experiment was recorded on a tape recorder, which acted later as the simulation input for the real-time monitor.
IV. ALGORITHM The wavelet analysis of the DHS at scale = 1 greatly enhances the contrast of embolic to normal DHS signal power. The MSA of the wavelet-processed DHS shows this enhancement (Fig. 1) . Detecting EHS can thus be facilitated by thresholding on the MSA. The threshold is set to be two times the mean peak of MSA of the past 1-minute wavelet-processed DHS signals on empirical grounds. Essentially, an adaptive thresholding is established which adapts to the possible change of magnitude of the DHS signals due to prolonged operation. In addition, the cumulative embolic energy is found to be linearly (log-log scale) related to the volume of air both from the bolus and continuous infusions. Hence, the clinically significant embolic air volume can be estimated based on the calibration curve obtained during sub-clinical VAE. The cumulative embolic air is monitored and alarming signal is issued once a predefined clinically significant embolic air volume is reached.
r'7 The DHS signals entering the monitor are processed by three main procedures, namely wavelet analysis at scale = 1, MSA of the wavelet-processed DHS and location of the peak of MSA. The tracings and various parameters are display in the panel of the real-time monitor (Fig. 2) . In the upper half of the panel shows, from top to bottom, the original DHS signal, the wavelet analysis of the DHS at scale = 1 and the MSA of the middle tracing. The monitor is designed to be operated in three modes which are detailed in the lower half of the panel. In the learning mode, the control baseline period of the DHS was fed to the monitor for calculating the mean energy of the wavelet-processed DHS and the mean peak of the MSA for normalization purpose in subsequent modes. Then, the DHS with bolus injection of small air volumes entered the monitor in the calibration mode so as to establish a calibration curve. Finally, the DHS with continuous infusion of larger air volumes was fed to the monitor in the monitoring mode. The embolic energy of the EHS is fitted to the calibration curve for estimating embolic air volume. In the lower right region of the panel shows the real-time trace of the cumulative embolic air volume (y-axis) against the infusion time (x-axis). The trace is cleared every 10 minutes in order to accommodate later traces and all the traces can be stored for future reference. This real-time trace is important and useful for anaesthetists to insure proper clinical treatments during surgery. Table  I . Except for the intercepts of Dog A, there was statistically no difference (P < 0.05 using Student's t-test [7] ) in the slopes and intercepts between the regression lines for both cases, reassuring that the clinically significant embolic air volume can be estimated based on the calibration curve obtained during sub-clinical VAE. Fig. 3 shows a typical plot of the cumulative embolic air volume against the infusion time, showing the gradual build-up of the embolic air volumes during infusion. The cumulative embolic air volume increased irregularly during the infusion period while it followed a linear trend in the intermission. We observed remarkable similarity in the EHS between the bolus injection and continuous infusion. The EHS due to continuous infusion was similar to that during a series of bolus injection. In fact, this was the Fig. 3 showed this fact. This phenomenon may probably reflect the non-linearity of the air emboli travelling from the external jugular vein to the right atrium. In the intermission, some traces of EHS were also detected and the cumulative embolic air volume was observed to increase linearly (Fig. 3) , which may probably due to the re-circulation of the air emboli within the heart chamber. This linear increase, if persists after surgery, may indicate that embolic air is still resident and suitable clinical treatments have to be done. Although our simulation experiment was carried out on dogs, similar results for humans are expected as they would share similar physiological conditions. As the heart rate of dogs is higher than that of adult humans, the feasibility of real-time monitoring of VAE in dogs also suggests the same results for humans. Fig. 3 . Plot of the estimated cumulative embolic air volume against the infusion time of 9.60 ml air for Dog A. Air infusion during the first half (0 to 300 seconds) while intermission in the second half (300 to 600 seconds).
One of the favourable features of our real-time monitor is the ability to estimate embolic air volumes.
During the continuous air infusion, the volume of each air emboli related to each EHS can be estimated based on the previously established calibration curve. The cumulative embolic air volume can thus be obtained by summing all the previous volume of air emboli. This cumulative embolic air volume is particular useful as it can be used to alert the anaesthetists at a predefined clinically significant embolic air volume (e.g. I ml) so that clinical treatments such as retrieval of air emboli using catheter can be performed without delay.
Another features of the real-time monitor is the adaptive thresholding which was firstly proposed in [SI. This thresholding technique acquires constantly the peaks of MSA of the previous wavelet-processed windowed DHS and computes the appropriate threshold for detecting EHS. This adaptive technique is more favourable than a fixed threshold in that reliable and robust detection can be achieved while false alarm is kept to a minimum. Besides, it can adapt to the drift of magnitude of the DHS in case the position of the ultrasonic probe is altered or some parameters of the surgical instruments are changed due to prolonged operation.
Though the DHS has a periodic rhythm (0.25 Hz) in its magnitude as a result of the chest wall movement produced by the ventilator, our wavelet method can still detect the EHS. Its sensitivity is 0.01 ml and the detection range is up to almost 10 ml, sufficient to cover both the sub-clinical and clinically significant embolic air volumes.
A real-time monitor for VAE was realized using the wavelet analysis of the DHS at scale = 1 and its MSA as the main algorithms. The real-time implementation is facilitated by windowing the continuous DHS, A/D converting the windowed DHS in the background and processing the previously AID converted windowed DHS using our algorithms. The clinically significant air emboli can be estimated based on the calibration curve obtained during sub-clinical VAE for a subject. The monitor can also keep track of the cumulative embolic air volumes and alerts the anaesthetists once a predefined clinically significant embolic air volume is reached.
